Medical doctors,” he said. “It’s physicians who are typically trained in internal medicine.” Yet, physicians who see patients for weight management often prescribe these medications without a mental health evaluation, he added.
While the GLP-1 drugs have shown promising results for weight loss and diabetes management, experts are cautioning against the potential risk of triggering or exacerbating eating disorders in some individuals. The sudden and significant weight loss associated with these drugs may lead to a skewed perception of food and eating habits, pushing some individuals towards restrictive eating behaviors that can spiral out of control.
It is essential for healthcare providers to screen patients for eating disorders before prescribing these medications for weight loss. Additionally, individuals who start using obesity medication should also seek support from a mental health provider to monitor their mental well-being and prevent any negative impacts on their relationship with food and eating habits.
While some doctors have not observed an increase in eating disorders among patients taking GLP-1 drugs, others have expressed concerns about the potential for misuse and the development or exacerbation of disordered eating behaviors. The case studies presented in the article highlight the importance of careful monitoring and evaluation of individuals prescribed these medications to ensure their safety and well-being, especially for those with a history of eating disorders or disordered eating behaviors.
Photo credit
www.nbcnews.com